These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
13. Uncovering the molecular mode of action of the antimalarial drug atovaquone using a bacterial system. Mather MW; Darrouzet E; Valkova-Valchanova M; Cooley JW; McIntosh MT; Daldal F; Vaidya AB J Biol Chem; 2005 Jul; 280(29):27458-65. PubMed ID: 15917236 [TBL] [Abstract][Full Text] [Related]
14. Cytochrome b mutations that modify the ubiquinol-binding pocket of the cytochrome bc1 complex and confer anti-malarial drug resistance in Saccharomyces cerevisiae. Kessl JJ; Ha KH; Merritt AK; Lange BB; Hill P; Meunier B; Meshnick SR; Trumpower BL J Biol Chem; 2005 Apr; 280(17):17142-8. PubMed ID: 15718226 [TBL] [Abstract][Full Text] [Related]
15. Inhibition of cytochrome bc1 as a strategy for single-dose, multi-stage antimalarial therapy. Stickles AM; Ting LM; Morrisey JM; Li Y; Mather MW; Meermeier E; Pershing AM; Forquer IP; Miley GP; Pou S; Winter RW; Hinrichs DJ; Kelly JX; Kim K; Vaidya AB; Riscoe MK; Nilsen A Am J Trop Med Hyg; 2015 Jun; 92(6):1195-201. PubMed ID: 25918204 [TBL] [Abstract][Full Text] [Related]
16. The antimalarial compound ELQ-400 is an unusual inhibitor of the bc Song Z; Iorga BI; Mounkoro P; Fisher N; Meunier B FEBS Lett; 2018 Apr; 592(8):1346-1356. PubMed ID: 29574797 [TBL] [Abstract][Full Text] [Related]